Indeed, a significant reduction of LYN, SYK, BTK and AKT protein levels (Figure 2A) was discernible in CLL cells upon HSP90-inhibition as reported recently [14], while our work was in progress. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.